SE0001151D0 - Method for producing a controlled-release composition - Google Patents

Method for producing a controlled-release composition

Info

Publication number
SE0001151D0
SE0001151D0 SE0001151A SE0001151A SE0001151D0 SE 0001151 D0 SE0001151 D0 SE 0001151D0 SE 0001151 A SE0001151 A SE 0001151A SE 0001151 A SE0001151 A SE 0001151A SE 0001151 D0 SE0001151 D0 SE 0001151D0
Authority
SE
Sweden
Prior art keywords
controlled
producing
pore
release composition
forming agent
Prior art date
Application number
SE0001151A
Other languages
English (en)
Swedish (sv)
Inventor
John Kendrup
Peter Fyhr
Original Assignee
Amarin Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Dev Ab filed Critical Amarin Dev Ab
Priority to SE0001151A priority Critical patent/SE0001151D0/xx
Publication of SE0001151D0 publication Critical patent/SE0001151D0/xx
Priority to AU2001239658A priority patent/AU2001239658A1/en
Priority to PCT/SE2001/000626 priority patent/WO2001074336A1/en
Priority to AT01914312T priority patent/ATE281156T1/de
Priority to JP2001572081A priority patent/JP4963767B2/ja
Priority to EP04025989A priority patent/EP1516616A1/de
Priority to DE60106889T priority patent/DE60106889T2/de
Priority to EP01914312A priority patent/EP1267842B1/de
Priority to US09/819,813 priority patent/US6974591B2/en
Priority to US11/255,073 priority patent/US20060159755A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0001151A 2000-03-31 2000-03-31 Method for producing a controlled-release composition SE0001151D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition
AU2001239658A AU2001239658A1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release preparation
PCT/SE2001/000626 WO2001074336A1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release preparation
AT01914312T ATE281156T1 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
JP2001572081A JP4963767B2 (ja) 2000-03-31 2001-03-23 制御放出性製剤の製法
EP04025989A EP1516616A1 (de) 2000-03-31 2001-03-23 Eine kontrollierte Freigabezusammensetzung mit spezifischen Poren-Bildnern im Filmüberzug
DE60106889T DE60106889T2 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
EP01914312A EP1267842B1 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
US09/819,813 US6974591B2 (en) 2000-03-31 2001-03-29 Method for producing a controlled-release preparation
US11/255,073 US20060159755A1 (en) 2000-03-31 2005-10-19 Method for producing a controlled release preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Publications (1)

Publication Number Publication Date
SE0001151D0 true SE0001151D0 (sv) 2000-03-31

Family

ID=20279094

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Country Status (8)

Country Link
US (2) US6974591B2 (de)
EP (2) EP1267842B1 (de)
JP (1) JP4963767B2 (de)
AT (1) ATE281156T1 (de)
AU (1) AU2001239658A1 (de)
DE (1) DE60106889T2 (de)
SE (1) SE0001151D0 (de)
WO (1) WO2001074336A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551617B1 (en) * 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
AU2003272504A1 (en) * 2002-09-20 2004-04-08 Andrx Labs Llc Multistage formulation containing a biguanide and thiazolidindione derivatives
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same
ZA200711123B (en) 2005-06-27 2009-08-26 Biovail Lab Int Srl Modified-release formulations of a bupropion salt
CA2645855C (en) 2006-03-16 2015-02-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
DE102006030860A1 (de) * 2006-07-04 2008-01-10 Universität Regensburg Oligomere von Isonitril-Metallkomplexen als Triplett-Emitter für OLED-Anwendungen
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
PL2432454T3 (pl) 2009-05-19 2017-10-31 Neuroderm Ltd Kompozycje do ciągłego podawania inhibitorów dopa-dekarboksylazy
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
PT2640358T (pt) 2010-11-15 2018-02-23 Neuroderm Ltd Administração contínua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos
EP2481411A1 (de) * 2011-01-27 2012-08-01 Ratiopharm GmbH Orale Dosierformen für modifizierte Freisetzung mit dem JAK3-Hemmer tasocitinib
NZ703341A (en) 2012-06-05 2016-11-25 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
EP2872121B1 (de) 2012-07-12 2018-09-05 SpecGx LLC Missbrauchssichere pharmazeutische zusammensetzungen mit verzögerter freisetzung
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
DK3116475T3 (da) 2014-03-13 2020-12-07 Neuroderm Ltd Dopa-decarboxylasehæmmersammensætninger
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
WO2020128062A1 (en) * 2018-12-21 2020-06-25 Re-Vana Therapeutics Ltd Ocular compositions
WO2021171972A1 (ja) * 2020-02-28 2021-09-02 株式会社Ｓｃｒｅｅｎホールディングス 固体製剤
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB587055I5 (de) * 1956-05-24
US4557925A (en) 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5376383A (en) 1988-11-21 1994-12-27 Merck & Co., Inc. Method for enhancing the lowering of plasma-cholesterol levels
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas

Also Published As

Publication number Publication date
US20060159755A1 (en) 2006-07-20
EP1267842B1 (de) 2004-11-03
JP4963767B2 (ja) 2012-06-27
US20010038853A1 (en) 2001-11-08
DE60106889D1 (de) 2004-12-09
ATE281156T1 (de) 2004-11-15
DE60106889T2 (de) 2006-03-23
EP1516616A1 (de) 2005-03-23
US6974591B2 (en) 2005-12-13
EP1267842A1 (de) 2003-01-02
WO2001074336A1 (en) 2001-10-11
JP2003528910A (ja) 2003-09-30
AU2001239658A1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
SE0001151D0 (sv) Method for producing a controlled-release composition
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
DE69933689D1 (de) Verfahren zur herstellung von oralen calcium zusammensetzungen
DK0377518T3 (da) Farmaceutisk præparat med langvarig frigivelse
DK0652747T3 (da) Morfinpræparat med reguleret frigivelse
TNSN91067A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
ATE380022T1 (de) Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
DE60136858D1 (de) Copolymer vom polycarbonsäure typ, verfahren zu seiner herstellung, zementadditiv und zementzusammensetzung
PT1166776E (pt) Processo para a preparacao de formas de apresentacao farmaceutica orais solidas com libertacao retardada da substancia activa
ZA200500716B (en) Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
EE04700B1 (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
CY1107559T1 (el) Μικροκοκκοι θειικης μορφινης, μεθοδος παρασκευης και φαρμακευτικα σκευασματα
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
BR9709858A (pt) Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto
EA199900205A1 (ru) Лекарственные формы для перорального введения, содержащие бета-лактамный антибиотик
EP0616802A4 (de) Orale zubereitung zur freisetzung im unteren verdauungstract.
EP1258254A4 (de) Zusammensetzungen zur verzögerten abgabe von physiologisch aktiven verbindungen die kaum wasserlösslich sind, verfahren zu deren herstellung und deren verwendung
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
DE69901062D1 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
EA199800553A1 (ru) Порошок вспенивателя и способ его получения
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
CY1107836T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενωση συμπυκνωμενης ινδολης